Narcolepsy

Clinical picture

• Irresistible daily sleep attacks lasting 10 to 20 minutes that are refreshing on waking, unlike the unrefreshing sleepiness of sleep apnea.
• Cataplexy is sudden bilateral loss of muscle tone triggered by laughter or surprise, with fully preserved consciousness and rapid recovery.
• Sleep paralysis and vivid hypnagogic or hypnopompic hallucinations at sleep transitions are frequently misread as a psychotic disorder.
• Nocturnal sleep is fragmented despite severe daytime sleepiness, and patients commonly report vivid dreams and dream enactment behavior.
• In children cataplexy may present as facial hypotonia, tongue protrusion, ptosis, and an unsteady gait rather than dramatic collapse.
• Automatic behaviors with amnesia, rapid weight gain, and precocious puberty in pediatric cases complete the clinical presentation.

Criteria snapshot

• Recurrent irrepressible need to sleep, lapses into sleep, or daytime napping occurring at least three times weekly over the past three months.
• Requires one of: cataplexy, low CSF hypocretin-1, or a nap study with mean sleep latency under 8 minutes plus two sleep-onset REM periods.
• DSM-5-TR subtypes the disorder by hypocretin deficiency, cataplexy status, autosomal dominant forms, and secondary medical causes.
• A sleep-onset REM period on the preceding overnight polysomnogram may substitute for one of the two required nap REM periods.
• Patients must be off REM-suppressing medication and adequately rested before testing or the multiple sleep latency test is uninterpretable.

Neurobiology

• Type 1 narcolepsy reflects loss of roughly 90% of lateral hypothalamic orexin/hypocretin neurons, giving CSF hypocretin-1 below 110 pg/mL.
• The mechanism is autoimmune: over 98% of type 1 cases carry HLA-DQB1*06:02, with T-cell reactivity directed at hypocretin neurons.
• Molecular mimicry with H1N1 influenza and the Pandemrix vaccine produced a documented incidence spike across Europe after 2009.
• Without orexin the wake-REM flip-flop switch becomes unstable, so REM phenomena intrude into wakefulness as cataplexy and sleep paralysis.
• Cataplexy is REM atonia occurring without REM sleep, mediated by pontine and medullary inhibition of spinal alpha motor neurons.
• Comorbid obesity, type 2 diabetes, and precocious puberty reflect broader hypothalamic dysfunction beyond sleep-wake regulation alone.

Psychology

• Misdiagnosis as depression, laziness, or malingering is near-universal and produces roughly a decade of accumulated shame before correct diagnosis.
• Cataplexy triggered by laughter teaches emotional suppression, so patients flatten their affect and withdraw socially in order to stay upright.
• Hypnagogic hallucinations with sleep paralysis are frequently mislabeled as psychosis, leading to unnecessary antipsychotic exposure.
• Academic and occupational failure is common despite intact ability, and formal accommodations often rescue trajectories more than dose increases.
• Depression affects roughly a third of patients and both worsens subjective sleepiness and confounds assessment of stimulant response.

Differential & comorbidity

• Rule out insufficient sleep syndrome first using actigraphy and a sleep diary, since it is the leading cause of a false-positive nap study.
• Obstructive sleep apnea coexists and must be treated before testing, because it independently produces sleep-onset REM periods.
• Idiopathic hypersomnia features long unrefreshing sleep with severe sleep inertia and no cataplexy or REM intrusion phenomena.
• Cataplexy mimics include syncope, atonic seizures, drop attacks, and functional events, with preserved consciousness the key discriminator.
• Obesity, depression, anxiety, ADHD, and REM sleep behavior disorder are all overrepresented and require concurrent management.

Pharmacologic treatment

• Modafinil 100-400 mg or armodafinil 150-250 mg is first-line for sleepiness; counsel on reduced hormonal contraceptive efficacy.
• Sodium oxybate or the low-sodium formulation, dosed twice nightly, is the only agent treating sleepiness, cataplexy, and disrupted sleep together.
• Pitolisant 17.8-35.6 mg is a histamine H3 inverse agonist that treats both sleepiness and cataplexy without controlled-substance scheduling.
• Solriamfetol 75-150 mg and traditional stimulants such as methylphenidate or amphetamine salts remain effective for residual sleepiness.
• Venlafaxine and SSRIs suppress cataplexy off-label, and abrupt discontinuation can precipitate rebound status cataplecticus.

Psychotherapy

• CBT adapted for narcolepsy targets shame, anticipatory anxiety about cataplexy, and avoidance of emotionally arousing situations.
• Psychoeducation reframing the symptoms as neurologic rather than characterological is the highest-yield early intervention for these patients.
• Behavioral scheduling of two or three planned 15 to 20 minute naps meaningfully reduces sleepiness burden alongside medication.
• Treat comorbid depression with psychotherapy where feasible, since several antidepressants complicate later cataplexy management.
• Family and school sessions correct attributions of laziness and establish realistic expectations for the adolescent patient.

Adjunct options

• A fixed sleep-wake schedule, adequate nocturnal sleep opportunity, and avoidance of alcohol and heavy meals reduce overall symptom burden.
• Secure formal accommodations including scheduled naps, flexible start times, and extended testing time under disability protections.
• Driving counseling is mandatory, with documented sleepiness control and adherence to state reporting requirements for lapses of consciousness.
• Track outcomes with the Epworth Sleepiness Scale and weekly cataplexy counts rather than global clinical impressions.
• Monitor cardiometabolic risk, blood pressure on stimulants, and sodium load when standard sodium oxybate is prescribed.

Clinical pearls

• Refreshing short naps suggest narcolepsy; unrefreshing long naps suggest something else.
• Sleep paralysis with hallucinations is REM intrusion, not psychosis.
• Treat coexisting apnea before an MSLT or the result is uninterpretable.